There's always hope for the company being taken over by a bigger player for their cxbladder product which I can tell you does have real clinical validity. However would advise caution there was a similar company years ago apparently in the same situation as PEB, clinical tool for prostate cancer that was actually okay clinically but the company just collapsed - no buy out or anything. Didn't matter how good the product was.